Dallas, TX, United States of America

Hulling Tan

This inventor holds 1 USPTO granted patent. Top assignees: Immunesensor Therapeutics, Inc., The University of Texas System. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hulling Tan. Retrieved from https://idiyas.com/inventor/hulling-tan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hulling Tan

Introduction

Hulling Tan is an accomplished inventor based in Dallas, TX. With one notable patent to his name, he has made significant contributions to the field of medical therapy.

Latest Patents

Hulling Tan holds a patent for "Quinoline cGAS antagonist compounds." This patent encompasses compounds that serve as cGAS antagonists, detailing methods of preparation, pharmaceutical compositions, and their applications in medical therapy.

Career Highlights

Hulling has worked with leading organizations such as Immunesensor Therapeutics, Inc. and the University of Texas System. His innovative work in these institutions has contributed to advancements in the medical science sector.

Collaborations

Throughout his career, Hulling has collaborated with esteemed colleagues like Jian Qiu and Qi Wei. Together, they have worked on various research projects that aim to push the boundaries of medical therapies and innovations.

Conclusion

Hulling Tan's dedicated work and innovative spirit continue to pave the way for advancements in medicine. Through his patent and collaborations, he has made a profound impact in his field, demonstrating the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…